13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001420506-23-001580
Total Value
$1.67B
Positions
48
Other Managers
0
Confidential Omitted
No
Holdings (48)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HILLEVAX INC | 43157M102 | 9,781,472 | $168.1M | 10.04% |
| 2 | CHINOOK THERAPEUTICS INC | 16961L106 | 4,345,559 | $167.0M | 9.97% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $144.8M | 8.65% |
| 4 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,871,803 | $129.3M | 7.72% |
| 5 | KRYSTAL BIOTECH INC | KRYS | 990,260 | $116.3M | 6.94% |
| 6 | MIRUM PHARMACEUTICALS INC | MIRM | 4,360,107 | $112.8M | 6.74% |
| 7 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,684,232 | $82.8M | 4.94% |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 3,708,838 | $77.6M | 4.64% |
| 9 | VERONA PHARMA PLC | 925050106 | 2,944,349 | $62.2M | 3.72% |
| 10 | VAXCYTE INC | PCVX | 1,164,405 | $58.2M | 3.47% |
| 11 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,167,222 | $35.7M | 2.13% |
| 12 | BRIDGEBIO PHARMA INC | BBIO | 1,988,876 | $34.2M | 2.04% |
| 13 | TARSUS PHARMACEUTICALS INC | TARS | 1,787,527 | $32.3M | 1.93% |
| 14 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,985,757 | $30.7M | 1.83% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 3,238,859 | $29.1M | 1.74% |
| 16 | DISC MEDICINE INC | IRON | 655,000 | $29.1M | 1.74% |
| 17 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,414,823 | $25.5M | 1.52% |
| 18 | REVOLUTION MEDICINES INC | RVMDW | 854,484 | $22.9M | 1.37% |
| 19 | THESEUS PHARMACEUTICALS INC | 88369M101 | 2,248,194 | $21.0M | 1.25% |
| 20 | ACADIA PHARMACEUTICALS INC | ACAD | 857,338 | $20.5M | 1.23% |
| 21 | MERUS N V | N5749R100 | 746,479 | $19.7M | 1.17% |
| 22 | ANAPTYSBIO INC | ANABV | 899,700 | $18.3M | 1.09% |
| 23 | COGENT BIOSCIENCES INC | COGT | 1,501,383 | $17.8M | 1.06% |
| 24 | TYRA BIOSCIENCES INC | TYRA | 1,028,013 | $17.5M | 1.05% |
| 25 | AEROVATE THERAPEUTICS INC | 008064107 | 994,858 | $17.1M | 1.02% |
| 26 | ENLIVEN THERAPEUTICS INC | ELVN | 830,983 | $17.0M | 1.01% |
| 27 | ORIC PHARMACEUTICALS INC | ORIC | 2,142,855 | $16.6M | 0.99% |
| 28 | TREVI THERAPEUTICS INC | TRVI | 6,881,090 | $16.4M | 0.98% |
| 29 | MORPHIC HLDG INC | 61775R105 | 265,511 | $15.2M | 0.91% |
| 30 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 393,000 | $12.5M | 0.75% |
| 31 | REATA PHARMACEUTICALS INC | 75615P103 | 100,430 | $10.2M | 0.61% |
| 32 | MACROGENICS INC | MGNX | 1,803,204 | $9.6M | 0.58% |
| 33 | REPLIMUNE GROUP INC | REPL | 386,762 | $9.0M | 0.54% |
| 34 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,746,857 | $8.9M | 0.53% |
| 35 | PROTHENA CORP PLC | PRTA | 127,900 | $8.7M | 0.52% |
| 36 | INTELLIA THERAPEUTICS INC | NTLA | 203,684 | $8.3M | 0.50% |
| 37 | ARVINAS INC | ARVN | 285,331 | $7.1M | 0.42% |
| 38 | EDGEWISE THERAPEUTICS INC | EWTX | 749,022 | $5.8M | 0.35% |
| 39 | IMMUNOVANT INC | IMVT | 300,000 | $5.7M | 0.34% |
| 40 | BLUEBIRD BIO INC | 09609G100 | 1,709,907 | $5.6M | 0.34% |
| 41 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 370,000 | $5.2M | 0.31% |
| 42 | SILENCE THERAPEUTICS PLC | SLNCF | 881,173 | $4.8M | 0.29% |
| 43 | GRITSTONE BIO INC | 39868T105 | 2,401,714 | $4.7M | 0.28% |
| 44 | SUTRO BIOPHARMA INC | STRO | 780,000 | $3.6M | 0.22% |
| 45 | ADC THERAPEUTICS SA | ADCT | 1,647,030 | $3.5M | 0.21% |
| 46 | ACLARIS THERAPEUTICS INC | ACRS | 264,377 | $2.7M | 0.16% |
| 47 | PASSAGE BIO INC | PASG | 1,850,000 | $1.7M | 0.10% |
| 48 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $1.0M | 0.06% |